Sector

Pharma & Biotech

2022 IP Profiles Survey

2022 IP Profiles Survey

28 February 2022

In September, Asia IP will publish the 2022 edition of Asia IP Profiles. This guide is the definitive resource for companies trying to identify the best IP practices in the region, and is based on editorial research, and surveys submitted by leading...

Chatbots: A way to immortalize the dead?

Chatbots: A way to immortalize the dead?

28 February 2022

When Microsoft secured a patent for conversational chatbots to mine data from a person’s social media history, observers wondered how it might affect the person’s intellectual property rights

Brain interfacing, copyright and the patent system

Brain interfacing, copyright and the patent system

28 February 2022

Brain interfacing has been gaining traction since Elon Musk’s investment in Neuralink. Lawyers discuss how future brain-computer collaborations might affect copyright and patent laws.

The Winners of the Asia IP 2021 Awards

The Winners of the Asia IP 2021 Awards

17 January 2022

You have spoken. The verdict is in. And the winners are...

India’s IP Experts

India’s IP Experts

17 January 2022

We reveal India's leading IP Experts

Asia IP’s editorial team reveals India’s top IP firms, practices

Asia IP’s editorial team reveals India’s top IP firms, practices

30 November 2021

And the winners of the 2021 Asia IP India Awards are...

IPOPHL collaborates with the Pharmaceutical Security Institute to combat the rise of counterfeit pharmaceuticals

IPOPHL collaborates with the Pharmaceutical Security Institute to combat the rise of counterfeit pha...

30 November 2021

Taiwan's IP Experts

Taiwan's IP Experts

16 September 2021

The ayes and nays of ‘covered’ and ‘disclosed’ in a patent

The ayes and nays of ‘covered’ and ‘disclosed’ in a patent

31 August 2021

AstraZeneca AB filed an application at the Delhi High Court seeking an interim injunction for restraining Emcure Pharmaceuticals Ltd. from making, selling, distributing, exporting or offering for sale products comprising the compound Ticagrelor under...

Malaysia’s IP Experts

Malaysia’s IP Experts

31 August 2021

Asia IP reveals the top 50 IP Experts in Malaysia!

Patentability of inventions relating to dosing regimen in China

Patentability of inventions relating to dosing regimen in China

31 August 2021

Although methods for the diagnosis and treatment of diseases are not granted patent rights in China, the CNIPA will allow an applicant to seek protection for inventions relating to the second medical use of a substance. Jiancheng Jiang explains the i...

Number of IP Filings In The Philippines Increaes By 20% In First Half

Number of IP Filings In The Philippines Increaes By 20% In First Half

30 August 2021

The total number of IP applications was 22,919. The most significant rise was in utility model (UM) submissions, which increased by 26% from 592 to 744 between January and June of last year.

Japan's IP Experts

Japan's IP Experts

31 July 2021

Asia IP reveals the 2021's top 50 IP Experts of Japan!

Favipiravir: Patent rejection in Thailand

Favipiravir: Patent rejection in Thailand

31 July 2021

Thailand’s Department of Intellectual Property (DIP) has since rejected a Thai patent application filed under the compulsory license system for a specific formulation Favipiravir in tablet form.

One of Taiwan’s new Covid-19 vaccines can be a game changer

One of Taiwan’s new Covid-19 vaccines can be a game changer

05 July 2021

A local expert dissects one of the patent applications and provides updates on other vaccines that are currently being developed in the jurisdiction.

Please wait while the page is loading...

loader